Ai Digital Biology
Riffyn Recognized as a Representative Vendor for Intelligent Process Development in 2021 Gartner® Market Guide for Lab Informatics
Sep 15, 2021
Riffyn named Representative Vendors of Intelligent Process Development (IPD) and LIMS
September 01, 2021 10:50 AM Eastern Daylight Time
OAKLAND, Calif.--(BUSINESS WIRE)--Riffyn, the leading SaaS provider of scientific lab informatics today announced that it has been recognized as a Representative Vendor in the two categories — Intelligent Process Development and LIMS — in the 2021 Gartner Market Guide for Laboratory Informatics1 report. Per the report, “Organizations are under extreme pressure to expedite discovery and their lab operations are not keeping up.” It states that “single-purpose lab IT applications for recording and socializing lab data undermine CIOs’ aggressive R&D, quality and manufacturing goals.”
Since 2016, healthcare organizations have seen 878 percent of growth in health data.AI and machine learning are becoming mainstream to R&D organziations’ lab of the future strategies. Riffyn’s patent backed cloud software, Riffyn Nexus® , is enabling biopharma and biotech companies to innovate faster with IPD.“We are honored to be recognized by Gartner in this report and are committed to enabling scientific organizations with Intelligent Process Development,” said Riffyn CEO Tim Gardner. “The outcome of IPD is shorter process development cycles and more predictive, right first time manufacturing processes. Our customers have access to a whole new level of insights into their processes by having data that is always machine learning ready.”Riffyn was recently named as the Sample Vendor in two categories of the 2021 Gartner Hype Cycle ™ for Life Science Manufacturing, Quality and Supply Chain.2 It already supports digital transformation at top biopharma and industrial biotech companies whose portfolios span from vaccines and medicines to sustainable materials and next-gen food products.
Gartner, “Market Guide for Lab Informatics,” Michael Shanler and Rohan Sinha, August 4, 2021.
Gartner, “Hype Cycle for Life Science Manufacturing, Quality and Supply Chain,” Michael Shanler, Andrew Stevens, Rick Franzosa, July 20, 2021.












